GSA Capital Partners’s Medtronic MDT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $5.36M | Buy |
68,541
+62,888
| +1,112% | +$5.07M | 0.34% | 14 |
|
|
2026
Q1 | $490K | Sell |
5,653
-12,505
| -69% | -$1.2M | 0.03% | 934 |
|
|
2025
Q4 | $1.74M | Buy |
18,158
+15,234
| +521% | +$1.48M | 0.15% | 123 |
|
|
2025
Q3 | $278K | Sell |
2,924
-19,708
| -87% | -$1.81M | 0.02% | 1245 |
|
|
2025
Q2 | $1.97M | Buy |
22,632
+10,956
| +94% | +$929K | 0.14% | 129 |
|
|
2025
Q1 | $1.05M | Sell |
11,676
-42,756
| -79% | -$3.83M | 0.09% | 320 |
|
|
2024
Q4 | $4.35M | Buy |
54,432
+49,368
| +975% | +$4.27M | 0.32% | 14 |
|
|
2024
Q3 | $456K | Sell |
5,064
-11,995
| -70% | -$1.01M | 0.03% | 964 |
|
|
2024
Q2 | $1.34M | Buy |
17,059
+12,114
| +245% | +$993K | 0.09% | 323 |
|
|
2024
Q1 | $431K | Buy |
4,945
+2,086
| +73% | +$178K | 0.03% | 979 |
|
|
2023
Q4 | $236K | Sell |
2,859
-1,274
| -31% | -$97.1K | 0.02% | 1236 |
|
|
2023
Q3 | $324K | Buy |
+4,133
| New | +$346K | 0.03% | 1034 |
|
|
2023
Q1 | – | Sell |
-7,315
| Closed | -$569K | – | 1754 |
|
|
2022
Q4 | $569K | Sell |
7,315
-8,196
| -53% | -$664K | 0.07% | 524 |
|
|
2022
Q3 | $1.25M | Buy |
15,511
+2,403
| +18% | +$216K | 0.17% | 85 |
|
|
2022
Q2 | $1.18M | Buy |
+13,108
| New | +$1.33M | 0.18% | 89 |
|
|
2022
Q1 | – | Sell |
-5,587
| Closed | -$578K | – | 1653 |
|
|
2021
Q4 | $578K | Buy |
+5,587
| New | +$647K | 0.07% | 513 |
|
|
2021
Q3 | – | Sell |
-5,680
| Closed | -$705K | – | 1640 |
|
|
2021
Q2 | $705K | Buy |
5,680
+2,307
| +68% | +$290K | 0.08% | 414 |
|
|
2021
Q1 | $398K | Buy |
+3,373
| New | +$395K | 0.07% | 474 |
|
|
2020
Q2 | – | Sell |
-5,963
| Closed | -$538K | – | 909 |
|
|
2020
Q1 | $538K | Buy |
5,963
+3,150
| +112% | +$335K | 0.13% | 138 |
|
|
2019
Q4 | $319K | Buy |
2,813
+413
| +17% | +$45.3K | 0.04% | 978 |
|
|
2019
Q3 | $261K | Sell |
2,400
-16,007
| -87% | -$1.67M | 0.04% | 1025 |
|
|
2019
Q2 | $1.79M | Sell |
18,407
-910
| -5% | -$83.1K | 0.2% | 59 |
|
|
2019
Q1 | $1.76M | Sell |
19,317
-1,522
| -7% | -$136K | 0.18% | 91 |
|
|
2018
Q4 | $1.9M | Sell |
20,839
-17,094
| -45% | -$1.6M | 0.22% | 58 |
|
|
2018
Q3 | $3.73M | Buy |
37,933
+7,045
| +23% | +$651K | 0.21% | 47 |
|
|
2018
Q2 | $2.64M | Buy |
+30,888
| New | +$2.58M | 0.13% | 152 |
|
|
2018
Q1 | – | Sell |
-32,506
| Closed | -$2.63M | – | 1738 |
|
|
2017
Q4 | $2.63M | Sell |
32,506
-8,624
| -21% | -$691K | 0.16% | 122 |
|
|
2017
Q3 | $3.2M | Buy |
41,130
+33,893
| +468% | +$2.81M | 0.22% | 35 |
|
|
2017
Q2 | $642K | Sell |
7,237
-19,675
| -73% | -$1.66M | 0.04% | 856 |
|
|
2017
Q1 | $2.17M | Sell |
26,912
-60,566
| -69% | -$4.73M | 0.12% | 225 |
|
|
2016
Q4 | $6.23M | Buy |
87,478
+81,466
| +1,355% | +$6.4M | 0.37% | 7 |
|
|
2016
Q3 | $519K | Buy |
+6,012
| New | +$524K | 0.03% | 1036 |
|
|
2016
Q2 | – | Sell |
-23,661
| Closed | -$1.77M | – | 1833 |
|
|
2016
Q1 | $1.77M | Sell |
23,661
-17,117
| -42% | -$1.29M | 0.11% | 230 |
|
|
2015
Q4 | $3.14M | Sell |
40,778
-10,719
| -21% | -$807K | 0.15% | 111 |
|
|
2015
Q3 | $3.45M | Sell |
51,497
-32,346
| -39% | -$2.38M | 0.17% | 89 |
|
|
2015
Q2 | $6.21M | Buy |
83,843
+68,544
| +448% | +$5.24M | 0.24% | 34 |
|
|
2015
Q1 | $1.19M | Sell |
15,299
-71,487
| -82% | -$5.42M | 0.05% | 712 |
|
|
2014
Q4 | $6.27M | Sell |
86,786
-17,931
| -17% | -$1.25M | 0.44% | 8 |
|
|
2014
Q3 | $6.49M | Buy |
104,717
+94,092
| +886% | +$5.98M | 0.34% | 45 |
|
|
2014
Q2 | $677K | Buy |
+10,625
| New | +$645K | 0.03% | 939 |
|
|
2014
Q1 | – | Sell |
-72,196
| Closed | -$4.14M | – | 1708 |
|
|
2013
Q4 | $4.14M | Buy |
72,196
+52,256
| +262% | +$2.96M | 0.33% | 29 |
|
|
2013
Q3 | $1.06M | Sell |
19,940
-3,785
| -16% | -$204K | 0.08% | 316 |
|
|
2013
Q2 | $1.22M | Buy |
+23,725
| New | +$1.17M | 0.14% | 164 |
|
Other funds holding MDT
GSA Capital Partners's MDT Position: Q2 2026 in Review
GSA Capital Partners increased its Medtronic (MDT) stake by 1,112% in Q2 2026, buying an estimated $5.07M and bringing the position to 68,541 shares worth $5.36M. The position accounts for 0.34% of the portfolio, ranked #14.
GSA Capital Partners first reported a position in MDT in Q2 2013 and has held it in 43 quarters since. The position peaked at $6.49M in Q3 2014. 2,128 funds tracked by Wall St. Rank hold MDT as of Q2 2026.
- GSA Capital Partners held 68,541 shares of Medtronic worth $5.36M as of Q2 2026.
- GSA Capital Partners bought 62,888 Medtronic shares in Q2 2026, an estimated $5.07M.
- Medtronic made up 0.34% of GSA Capital Partners's portfolio in Q2 2026, its #14 holding.
- GSA Capital Partners first reported a position in Medtronic in Q2 2013 and has held it in 43 quarters since.
- GSA Capital Partners's Medtronic position peaked at $6.49M in Q3 2014.
- 2,128 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.
Based on GSA Capital Partners's 13F filing for Q2 2026, filed 6 Aug 2026.